Form 4 Tracker
TABUTEAU HERRIOT

Director, Chief Executive Officer, 10% Owner · 6 filings · Latest: Aug 5, 2026

Axsome Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
AXSM
TABUTEAU HERRIOTDirector, Chief Executive Officer, 10% OwnerAug 6, 2026
Sale
$213.954,660$997.0K7,229
AXSM
TABUTEAU HERRIOTDirector, Chief Executive Officer, 10% OwnerAug 6, 2026
Option Exercise
$4.954,660$23.1K11,889
AXSM
TABUTEAU HERRIOTDirector, Chief Executive Officer, 10% OwnerAug 5, 2026
Sale
$212.0145,004$9.5M7,229
AXSM
TABUTEAU HERRIOTDirector, Chief Executive Officer, 10% OwnerAug 5, 2026
Option Exercise
$4.9545,004$222.8K52,233
AXSM
Herriot Tabuteau—Aug 6, 2026
Proposed Sale
$210.134,660$979.2K—
AXSM
Herriot Tabuteau—Aug 5, 2026
Proposed Sale
$212.8545,004$9.6M—
AXSM
TABUTEAU HERRIOTDirector, Chief Executive Officer, 10% OwnerJul 1, 2026
Sale
$240.2549,666$11.9M7,229
AXSM
TABUTEAU HERRIOTDirector, Chief Executive Officer, 10% OwnerJul 1, 2026
Option Exercise
$4.9549,666$245.8K56,895
AXSM
Herriot Tabuteau—Jul 1, 2026
Proposed Sale
$240.6649,666$12.0M—
AXSM
Herriot Tabuteau—Jun 9, 2026
Proposed Sale
$245.6449,670$12.2M—
AXSM
TABUTEAU HERRIOTDirector, Chief Executive Officer, 10% OwnerJun 9, 2026
Sale
$241.0149,670$12.0M7,229
AXSM
TABUTEAU HERRIOTDirector, Chief Executive Officer, 10% OwnerJun 9, 2026
Option Exercise
$4.9549,670$245.9K56,899
AXSM
TABUTEAU HERRIOTDirector, Chief Executive Officer, 10% OwnerFeb 2, 2026
Sale
$185.6032,410$6.0M7,229
AXSM
TABUTEAU HERRIOTDirector, Chief Executive Officer, 10% OwnerFeb 2, 2026
Option Exercise
$8.0232,410$259.9K39,639
AXSM
Herriot Tabuteau—Feb 2, 2026
Proposed Sale
$185.8832,410$6.0M—
AXSM
Herriot Tabuteau—Jan 7, 2026
Proposed Sale
$170.6931,261$5.3M—
AXSM
Herriot Tabuteau—Jan 6, 2026
Proposed Sale
$171.8829,450$5.1M—
AXSM
Herriot Tabuteau—Jan 5, 2026
Proposed Sale
$171.4978,703$13.5M—
AXSM
Herriot Tabuteau—Dec 4, 2025
Proposed Sale
$148.0410,558$1.6M—
AXSM
Herriot Tabuteau—Dec 3, 2025
Proposed Sale
$147.8120,163$3.0M—

Page 1 of 2

Next →